When the expression of pro-inflammatory markers was quantified in EAT of CAD patients with type 2 diabetes who had undergone surgery, pioglitazone, a thiazolidinedione drug, significantly reduced the expression of IL-1β, IL-1Ra, and IL-10 [103]. The gene discussed is IL1B; the disease is coronary artery disorder.